198 related articles for article (PubMed ID: 23257507)
1. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
4. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
5. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
Sakkaki S; Gangarossa G; Lerat B; Françon D; Forichon L; Chemin J; Valjent E; Lerner-Natoli M; Lory P
Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
[TBL] [Abstract][Full Text] [Related]
6. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Choe W; Messinger RB; Leach E; Eckle VS; Obradovic A; Salajegheh R; Jevtovic-Todorovic V; Todorovic SM
Mol Pharmacol; 2011 Nov; 80(5):900-10. PubMed ID: 21821734
[TBL] [Abstract][Full Text] [Related]
7. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Marger F; Gelot A; Alloui A; Matricon J; Ferrer JF; Barrère C; Pizzoccaro A; Muller E; Nargeot J; Snutch TP; Eschalier A; Bourinet E; Ardid D
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11268-73. PubMed ID: 21690417
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ca
Picard E; Carvalho FA; Agosti F; Bourinet E; Ardid D; Eschalier A; Daulhac L; Mallet C
Br J Pharmacol; 2019 Apr; 176(7):950-963. PubMed ID: 30714145
[TBL] [Abstract][Full Text] [Related]
9. Essential role of Ca
Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
[TBL] [Abstract][Full Text] [Related]
10. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
[TBL] [Abstract][Full Text] [Related]
11. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
Kumari N; Bhargava A; Rath SN
Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
[TBL] [Abstract][Full Text] [Related]
12. Ca
Tracy ME; Tesic V; Stamenic TT; Joksimovic SM; Busquet N; Jevtovic-Todorovic V; Todorovic SM
Neuropharmacology; 2018 Jun; 135():343-354. PubMed ID: 29578032
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Takahashi T; Aoki Y; Okubo K; Maeda Y; Sekiguchi F; Mitani K; Nishikawa H; Kawabata A
Pain; 2010 Jul; 150(1):183-191. PubMed ID: 20546998
[TBL] [Abstract][Full Text] [Related]
15. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of Ca
Matsui K; Tsubota M; Fukushi S; Koike N; Masuda H; Kasanami Y; Miyazaki T; Sekiguchi F; Ohkubo T; Yoshida S; Mukai Y; Oita A; Takada M; Kawabata A
J Pharmacol Sci; 2019 Jul; 140(3):310-312. PubMed ID: 31492577
[TBL] [Abstract][Full Text] [Related]
17. T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Nguyen SJ; Surles NO; Yao L; Barrow JC; Uebele VN; Renger JJ; Clark J; Hutson PH
Neuropharmacology; 2012 Mar; 62(3):1413-21. PubMed ID: 21110986
[TBL] [Abstract][Full Text] [Related]
18. In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy.
Messinger RB; Naik AK; Jagodic MM; Nelson MT; Lee WY; Choe WJ; Orestes P; Latham JR; Todorovic SM; Jevtovic-Todorovic V
Pain; 2009 Sep; 145(1-2):184-95. PubMed ID: 19577366
[TBL] [Abstract][Full Text] [Related]
19. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
20. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
